Citius Oncology Inc [NASDAQ: CTOR] traded at a high on Monday, posting a 39.85 gain after which it closed the day’ session at $0.93.
The results of the trading session contributed to over 69901635 shares changing hands. Over the past one week, the price volatility of Citius Oncology Inc stands at 33.93% while the volatility over the past one month is 18.86%.
The market cap for CTOR stock reached $66.54 million, with 71.55 million shares outstanding and 3.52 million shares in the current float. Compared to the average trading volume of 128.15K shares, CTOR reached a trading volume of 69901635 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Citius Oncology Inc [CTOR]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CTOR shares is $3.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CTOR stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Maxim Group have made an estimate for Citius Oncology Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 27, 2024.
The Average True Range (ATR) for Citius Oncology Inc is set at 0.15 The Price to Book ratio for the last quarter was 1.61, with the Price to Cash per share for the same quarter was set at 0.00.
How has CTOR stock performed recently?
Citius Oncology Inc [CTOR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 30.99. With this latest performance, CTOR shares dropped by -21.85% in over the last four-week period, additionally sinking by -34.97% over the last 6 months – not to mention a drop of -91.51% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CTOR stock in for the last two-week period is set at 54.94, with the RSI for the last a single of trading hit 62.65, and the three-weeks RSI is set at 50.77 for Citius Oncology Inc [CTOR]. The present Moving Average for the last 50 days of trading for this stock 1.0386, while it was recorded at 0.7368 for the last single week of trading, and 3.7749 for the last 200 days.
Citius Oncology Inc [CTOR]: Deeper insight into the fundamentals
Citius Oncology Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.06 and a Current Ratio set at 0.39.
Insider trade positions for Citius Oncology Inc [CTOR]
There are presently around $0.89%, or 18.10%% of CTOR stock, in the hands of institutional investors.
